Neumora Therapeutics, Inc. Common Stock / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €0.00
    Gross profit
    €0.00
    SG&A expenses
    €57.47M
    R&D expenses
    €169.01M
    EBITDA
    -€226.21M
    D&A
    €267.96K
    EBIT
    -€226.47M
    Interest expenses
    €0.00
    EBT
    -€215.65M
    Tax expenses
    €156.66K
    Net income
    -€215.81M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €14.07M
    Changes in working capital
    €3.50M
    Operating cash flow
    -€167.52M
    Capex
    -€663.47K
    Other investing cash flow
    €1.28M
    Net investing cash flow
    €113.64M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €7.87M
    Debt repayment
    €0.00
    Other financing cash flow
    €18.72M
    Net financing cash flow
    €30.44M
    Foreign exchange effects
    €0.00
    Net change in cash
    -€22.39M
    Cash at end of period
    €106.60M
    Free cash flow
    -€168.18M

    Balance sheet

    Cash and cash equivalents
    €106.60M
    Cash and short-term investments
    €186.28M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €4.56M
    Total current assets
    €190.83M
    Property, plant & equipment
    €529.06K
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €255.12K
    Total non-current assets
    €784.18K
    Total assets
    €191.61M
    Accounts payable
    €551.32K
    Short-term debt
    €146.39K
    Other current liabilities
    €23.10M
    Total current liabilities
    €18.11M
    Long-term debt
    €290.21K
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €16.65M
    Total non-current liabilities
    €16.94M
    Total liabilities
    €35.05M
    Common stock
    €13.70K
    Retained earnings
    -€914.26M
    Other equity
    -€12.84K
    Total equity
    €156.56M
    Total liabilities and shareholders' equity
    €191.61M

    Company information

    Market capitalization
    €104.42M
    Employees
    110
    Enterprise Value
    €23.16M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -137.8%
    ROA
    -112.6%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -159.8%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€1.96M

    Notifications